Black Hawk Acquisition Corp and Vesicor enter financing agreements with Meteora on Sept. 22
BKHA•Black Hawk Acquisition Corp and Vesicor entered financing agreements with Meteora on Sept. 22, including a forward purchase agreement for up to 1.35 million shares and a provision allowing Vesicor Therapeutics Holdings to sell up to $200 million of common stock to Meteora over 36 months.
1. Financing agreements
A filing says Black Hawk Acquisition Corp and Vesicor entered financing agreements with Meteora on Sept. 22. The forward purchase agreement covers up to 1.35 million shares, and Vesicor Therapeutics Holdings may sell up to $200 million of common stock to Meteora over 36 months. Black Hawk plans to domesticate as a Delaware corporation and change its name to Vesicor Therapeutics Holdings; it will pay Meteora the final redemption price less $0.75 per backstop investor share.
